IL10 and gastric cancer: Therefore, we conducted this meta-analysis to further update the evidence of evidence-based medicine, deeply clarify the role of IL-10 819 gene polymorphism in gastric cancer, provide reference for clinical work, and better evaluate the potential correlation between IL-10 819 gene polymorphism and gastric cancer risk.